The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,134.00
Bid: 12,134.00
Ask: 12,136.00
Change: -162.00 (-1.32%)
Spread: 2.00 (0.016%)
Open: 12,226.00
High: 12,266.00
Low: 12,068.00
Prev. Close: 12,296.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Wall St advances, dollar declines as remarkable year nears finish line

Wed, 30th Dec 2020 16:05

* All three major U.S. stock averages higher

* Dollar sinks to lowest since April 2018

* Stimulus check negotiations continue in Washington

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh
(Updates to U.S. market open, changes dateline to NEW YORK (was
LONDON), changes byline)

By Stephen Culp

NEW YORK, Dec 30 (Reuters) - Wall Street advanced and the
dollar dipped to its lowest in more than two years on Wednesday,
the penultimate trading day in an extraordinary year of
pandemic, recession and recovery.

All three major U.S. stock indexes were up in a broad rally,
as impending stimulus and the ongoing rollout of COVID-19
vaccines fed optimism over economic recovery in 2021.

"I would caution against reading too much into trading
action this week because it's a shortened week and volumes are
typically down, so there tends to be more volatility," said
Chuck Carlson, chief executive officer at Horizon Investment
Services in Hammond, Indiana.

"The dollar is a continuation of what we've seen in the last
few months," Carlson added. "This is partly in anticipation that
since Europe had a deeper decline, its rebound will have more of
a snap-back."

U.S. Senate Majority Leader Mitch McConnell introduced a
bill late Tuesday that combines beefier $2,000 direct fiscal aid
payments to Americans with provisions involving social media
company protections and election security.

Britain approved a coronavirus vaccine developed by Oxford
University and AstraZeneca in the latest development in
the rapid progression, testing, approval and deployment of drugs
to battle the disease.

The Dow Jones Industrial Average rose 165.7 points,
or 0.55%, to 30,501.37, the S&P 500 gained 13.87 points,
or 0.37%, to 3,740.91 and the Nasdaq Composite added
34.01 points, or 0.26%, to 12,884.23.

European stocks reversed gains and headed slightly lower as
investors took profits in the wake of strong gains.

The pan-European STOXX 600 index lost 0.13% and
MSCI's gauge of stocks across the globe gained
0.49%.

Emerging market stocks rose 1.58%. MSCI's broadest index of
Asia-Pacific shares outside Japan closed 1.67%
higher, while Japan's Nikkei lost 0.45%.

U.S. Treasury yields were essentially flat on Wednesday
morning in thin trading as investors bet that Republicans were
unlikely to approve the passage of proposed $2000 stimulus
checks.

Benchmark 10-year notes last fell 1/32 in price
to yield 0.9364%, from 0.935% late on Tuesday.

The 30-year bond last fell 4/32 in price to
yield 1.679%, from 1.674% late on Tuesday.

The dollar fell the lowest since April 2018 against a basket
of world currencies as investors bet on more fiscal support and
positioned for year-end in light trading volume.

The dollar index fell 0.41%, with the euro up
0.36% to $1.2291.

The Japanese yen strengthened 0.42% versus the greenback at
103.15 per dollar, while Sterling was last trading at
$1.3608, up 0.80% on the day.

Crude oil prices gained ground on the back of the weaker
dollar and a dip in U.S. inventories.

U.S. crude rose 1.27% to $48.61 per barrel and Brent
was last at $51.33, up 0.47% on the day.

Gold gained ground as the safe-haven metal countered a dip
in the greenback.

Spot gold added 0.3% to $1,884.41 an ounce.

(Editing by Larry King and Nick Zieminski)

More News
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.